Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-08-25

Clinical Trial Update: A Study of LY900014 Versus Insulin Lispro (Humalog) on High Blood Sugar in Participants With Type 1 Diabetes Who Use Insulin Pumps [Phase 1]

View source ↗

Summary

Phase 1 trial comparing LY900014 to insulin lispro (Humalog) in type 1 diabetes patients using insulin pumps has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Humalog (insulin lispro)
  • LY900014

Snippet

Sponsor: Eli Lilly and Company | Conditions: Diabetes Mellitus, Type 1 | Phase 1 | Status: COMPLETED | Results posted: 2021-08-25